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Abstract
Introduction: Oxysterol binding protein Related Proteins (ORPs) mediate intracellular lipid transport and homeostatic
regulation. ORP8 downregulates ABCA1 expression in macrophages and cellular cholesterol efflux to apolipoprotein A-I. In
line, ORP8 knockout mice display increased amounts of HDL cholesterol in blood. However, the role of macrophage ORP8 in
atherosclerotic lesion development is unknown.
Methods and Results: LDL receptor knockout (KO) mice were transplanted with bone marrow (BM) from ORP8 KO mice and
C57Bl/6 wild type mice. Subsequently, the animals were challenged with a high fat/high cholesterol Western-type diet to
induce atherosclerosis. After 9 weeks of Western-Type diet feeding, serum levels of VLDL cholesterol were increased by 50%
in ORP8 KO BM recipients compared to the wild-type recipients. However, no differences were observed in HDL cholesterol.
Despite the increase in VLDL cholesterol, lesions in mice transplanted with ORP8 KO bone marrow were 20% smaller
compared to WT transplanted controls. In addition, ORP8 KO transplanted mice displayed a modest increase in the
percentage of macrophages in the lesion as compared to the wild-type transplanted group. ORP8 deficient macrophages
displayed decreased production of pro-inflammatory factors IL-6 and TNFa, decreased expression of differentiation markers
and showed a reduced capacity to form foam cells in the peritoneal cavity.
Conclusions: Deletion of ORP8 in bone marrow-derived cells, including macrophages, reduces lesion progression after 9
weeks of WTD challenge, despite increased amounts of circulating pro-atherogenic VLDL. Reduced macrophage foam cell
formation and lower macrophage inflammatory potential are plausible mechanisms contributing to the observed reduction
in atherosclerosis.
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Introduction
ORPs are Oxysterol binding protein Related Proteins and
comprise an evolutionary conserved family of 12 members.
Although the family as a whole has a range of functions, a
unifying theme is that ORPs can act as sterol sensors communi-
cating with different signaling pathways [1]. Sterol signaling
mediates several processes important to macrophage function in
atherosclerosis, such as macrophage cholesterol efflux, pro-
inflammatory signaling and the ability of macrophages to
differentiate to functionally diverse subtypes [2,3,4]. Previous
studies have demonstrated that altering the expression of ORPs in
macrophages results in changes in cellular function and athero-
sclerosis susceptibility. Silencing of ORP1L reduced cholesterol
efflux from macrophages, while overexpression of ORP1L led to
increased atherosclerosis development in Low-Density Lipoprotein
receptor knockout (LDLr KO) mice [5,6]. ORP3 overexpression
inhibits phagocytosis by macrophages, and macrophage intracel-
lular cholesterol transport is disrupted in cells deficient in ORP5
[7,8]. Furthermore, mutations in the ORP7 gene are associated
with increased LDL and total cholesterol, risk factors for
atherosclerosis [9]. Additionally, ORP8 is a potentially interesting
target for atherosclerosis research.
In humans, mutations in the ORP8 gene are associated with
changes in High-Density Lipoprotein (HDL) cholesterol levels in
blood [10]. Furthermore, ORP8 is expressed by macrophages in
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human atherosclerotic lesions [11]. THP-1 macrophages in which
ORP8 has been knocked down display an increased ability to
efflux cholesterol to nascent HDL particles due to increased
expression of ATP-Binding Cassette transporter A1 (ABCA1),
which is essential for cholesterol transport to lipid-poor apoAI, the
primary apolipoprotein of HDL [11]. Similarly, female ORP8 KO
mice display a markedly increased expression of ABCA1 in the
liver, as well as increased levels of HDL cholesterol and ApoAI
particles in blood [12,13]. This indicates a role for ORP8 as a
regulator of cellular cholesterol metabolism and efflux.
The aim of the current study is to investigate the effects of
ORP8 deletion in macrophages on atherosclerotic lesion develop-
ment. Hereto irradiated LDLr KO mice were transplanted with
ORP8 KO bone marrow (BM) and fed a high fat/high cholesterol
Western-Type Diet (WTD) for periods of 6 and 9 weeks. We show
that mice receiving ORP8 KO BM developed smaller atheroscle-
rotic plaques despite increased levels of pro-atherogenic lipopro-
teins and propose a possible mechanism for the observed decrease
in atherosclerosis.
Materials and Methods
Perivascular Collar Placement
LDL receptor knockout (LDLr KO) mice were obtained from
the Jackson Laboratory and bred at the Gorlaeus Laboratories in
Leiden, the Netherlands.
To assess gene expression during atherosclerotic plaque
development, mice were fed a high-fat/high-cholesterol Western-
Type Diet (WTD), containing 15% cacao butter and 0.25%
cholesterol (WTD; Special Diet Services) for 2, 4, 6, 8, 10 and 12
weeks. At two weeks a baseline group was sacrificed and
atherosclerotic carotid artery lesions were induced by perivascular
collar placement as described previously [14]. At the end of the
WTD feeding period the mice were anaesthetized using a mix of
rompun, ketamine and atropine at a lethal dose. Mice were then
exsanguinated and perfused with PBS.
Animal experiments were approved by the Ethics Committee
for Animal Experiments of Leiden University (permit number
08015) and performed at the Gorlaeus Laboratories of the Leiden
Academic Center for Drug Research in accordance with the
National Laws and the Directive 2010/63/EU of the European
Parliament.
Bone Marrow-Derived Macrophage Generation and
Culturing
Bone Marrow was isolated from ORP8 KO male mice (age 10
weeks). Bone marrow cells were plated in DMEM/20% FCS/1%
penicillin/1% streptomycin and differentiated into macrophages
by addition of 30% L929 cell-conditioned media (as a source of M-
CSF) for 7 days according to Van Eck et al. [15] Macrophages
were incubated for 24 h in cell culture plates (Greiner Bio-One)
the absence or presence of 100 ng/mL LPS (Salmonella Typhosa,
Sigma) or 20 ng/mL IL-4 (Sigma) and subsequently lysed for
mRNA extraction or analyzed by FACS.
Flow Cytometry Analysis
BMDMs were stained using antibodies against CD40 and
CD80 (eBioscience) and analyzed on a FACS Canto II (BD
Biosciences, Mountain View, CA).
Cytokine Quantification
Concentrations of murine TNFa and IL-6 in the supernatant of
BMDMs were assayed using an ELISA kit according to the
manufacturer’s protocol (BD Bioscience). Absorbance was detect-
ed at 450 nm.
mRNA Expression Analysis by Microarray and Real Time
PCR
Carotid arteries with collar-induced plaques of female LDLr
KO mice which were fed WTD for 2, 4, 6, 8, 10 and 12 weeks
were isolated. Samples were digested with proteinase K and
mechanically homogenized. Total RNA from samples was isolated
using the guanidinium thiocyanate (GTC) method [16] and a
microarray was performed by Service XS (Leiden, The Nether-
lands).
Furthermore, total RNA from Bone Marrow-Derived Macro-
phages (BMDMs) was isolated using the same GTC method and
reverse transcribed using a RevertAid M-MuLV enzyme (Fer-
mentas, Burlington, Canada). The mRNA expression levels were
assessed by real time PCR (ABI PRISM 7500; Applied Biosystems,
Foster City, CA) using SYBR Green technology (Applied
Biosystems). The average of GAPDH and 36B4 or ß-actin
expression was used as a housekeeping control.
Bone Marrow Transplantation
To study the effect of ORP8 deletion in hematopoietic cells,
bone marrow (BM) of male ORP8 KO mice and WT controls (age
12 weeks) was obtained from the laboratory of Dr. Olkkonen
(Minerva Foundation Institute for Medical Research, Helsinki,
Finland) for transplantation to female LDLr KO mice (age 12
weeks) at the Leiden Academic Centre for Drug Research. In
short, 56106 bone marrow cells were injected into the tail vein of
lethally irradiated recipients [15].
After 8 weeks recovery, recipient mice were fed WTD for 6 and
for 9 weeks. At the end of the WTD feeding period the mice were
anaesthetized using a mix of rompun, ketamine and atropine at a
lethal dose, after which peritoneal cells were isolated by peritoneal
lavage with PBS. Mice were then exsanguinated, perfused with
PBS, and organs were harvested.
Serum cholesterol, triglycerides and cytokines
Serum concentrations of free cholesterol were determined by
enzymatic colorimetric assays with 0.048 U/mL cholesterol
oxidase (228250, Calbiochem) and 0.065 U/mL peroxidase
(P8375, Sigma) in reaction buffer (1.0 KPi buffer, pH = 7.7
containing 0.01 M phenol, 1 mM 4-amino-antipyrine, 1% poly-
oxyethylene-9-laurylether, and 7.5% methanol). For the determi-
nation of total cholesterol, 0.03 U/mL cholesteryl esterase
(228180, Calbiochem) was added to the reaction solution.
Absorbance was read at 490 nm. Serum triglycerides were
measured using a colorimetric assay (Roche Diagnostics, Mann-
heim Germany) according to the manufacturer’s instructions. The
distribution of cholesterol and triglycerides over the different
lipoproteins in serum was determined by fractionation of 25 mL of
serum of each mouse using a Superose 6 column (3.26300 mm,
Smart-System; Pharmacia, Uppsala, Sweden). Total cholesterol
content of the effluent was determined as described above.
Concentrations of murine TNFa and IL-6 in the plasma were
assayed using an ELISA kit according to the manufacturer’s
protocol (BD Bioscience). Absorbance was detected at 450 nm.
Blood Cell Analysis
An automated Sysmex XT-2000iV Veterinary Haematology
analyzer (Sysmex Corporation) was used to analyze leukocyte
numbers and composition in blood and peritoneal leukocyte
samples.
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Macrophage cholesterol efflux studies
Bone marrow-derived macrophages were incubated with
0.5 mCi/mL 3H-cholesterol in DMEM/0.2% free fatty acid free
BSA for 24 hours at 37uC. To determine cholesterol loading, cells
were washed three times with washing buffer (50 mmol/L Tris,
containing 0.9% NaCl, 1 mmol/L EDTA, 5 mmol/L CaCl2,
pH 7.4), lysed in 0.1 mol/L NaOH, and the radioactivity was
determined by liquid scintillation counting. Cholesterol efflux was
studied by incubating the cells with DMEM/0.2% BSA alone, or
with DMEM/0.2% BSA supplemented with either 10 mg/mL
apolipoprotein AI (Calbiochem) or 50 mg/mL human HDL
(isolated according to Redgrave, as described previously [17]).
Radioactivity in the medium was determined by scintillation
counting after 24 hours of incubation. Cholesterol efflux was
defined as (dpmmedium/dpmcell+dpmmedium)6100%.
Histological Analysis of the Aortic Root
Serial sections (7 mm) of the aortic root were cut using a Leica
CM3050S cryostat and stained for lipids using oil red-O. The
atherosclerotic lesion areas in oil red-O stained cryostat sections of
the aortic root were quantified using the Leica image analysis
system, consisting of a Leica DMRE microscope coupled to a
video camera and Leica Qwin Imaging software (Leica Ltd,
Cambridge, UK). Mean lesion area (in mm2) was calculated from
10 consecutive oil red-O stained sections, starting at the
appearance of the tricuspid valves. For the assessment of the
macrophage area, sections were immunolabeled with MOMA-2
(Research Diagnostics Inc; dilution 1:50). The MOMA-2-positive
lesion area was subsequently quantified using the Leica image
analysis system and expressed as a fraction of total lesion area.
Apoptosis in the plaque was visualized using an In-Situ Cell Death
Detection Kit (POD) (11 684 817 910, Roche) as per manufac-
turer’s instructions. The tissue was counter stained using 0.3%
Methyl Green for 2 minutes. Methyl Green positive nuclei and
TUNEL positive nuclei in the plaque were counted and the
fraction of TUNEL positive nuclei of total Methyl Green positive
nuclei was calculated. Furthermore, presence of CD3+ T cells in
aortic root sections was visualized using an anti-CD3 antibody
(RM-9107, Thermo Scientific; dilution 1:150). Leica Qwin
software was used to quantify adventitia size in the stained
sections. CD3+ T cells were quantified and normalized for
adventitia size. A Masson Trichrome kit consisting of Biebrich
Scarlet Acid Fuchsin, Phosphotungstic Acid, Phosphomolybdic
Acid and Aniline Blue was used according to manufacturer’s
instructions (Procedure HT15) to visualize plaque collagen.
Statistical Analysis
Statistically significant differences were tested with the appro-
priate tests as indicated using Graphpad Prism software. The
probability level (alpha) for statistical significance was set at 0.05.
Results are expressed as an average 6 SEM.
Results
Expression of ORP8 is detectable in the atherosclerotic
plaque and correlates with expression of macrophage
marker CD68
Atherosclerotic plaques were induced in the carotid artery of
LDLr KO mice by surgically placing a collar around the carotid
artery and subjecting the animals to an atherogenic Western-Type
Diet (WTD) for up to 12 weeks. Animals were sacrificed every two
weeks starting at two weeks after collar placement. RNA was
isolated from the carotid arteries with atherosclerotic lesions and
analyzed by microarray. RNA expression of ORP8 was increased
during atherosclerosis progression up to 66% after 12 weeks of
WTD feeding (P,0.05, figure 1A). Expression of CD68, indicative
of macrophage infiltration, in the collar-induced plaques followed
a strikingly similar pattern to the expression pattern of ORP8. At
12 weeks of WTD feeding expression of CD68 was increased 17-
fold (P,0.01, figure 1A). Relative expression of ORP8 and CD68
were plotted against each other, and linear regression analysis
showed a correlation between ORP8 and CD68 expression in the
atherosclerotic carotid arteries, indicating that ORP8 is primarily
expressed by macrophages in the murine lesions (P,0.001,
figure 1B).
Decreased expression of macrophage differentiation
markers, pro-inflammatory cytokines and co-stimulatory
molecules by ORP8 KO BMDMs
Next, the effects of ORP8 deficiency on macrophage gene
expression were investigated. Macrophages are capable of
Figure 1. ORP8 expression detected in murine atherosclerotic
plaques correlates with expression of CD68. mRNA was isolated
from collar-induced plaques located in the carotid artery of LDLr KO
mice. Samples were taken at 2 week intervals from week 2 baseline until
week 12. Expression of ORP8 and the monocyte/macrophage marker
CD68 was measured at each timepoint by microarray analysis and
normalized for expression at baseline. A) ORP8 was found to be
upregulated during plaque progression, as was CD68 (* P,0.05; $$,
0.01, respectively). N = 3, values are expressed as mean 6 SEM.
Significance was assessed by ANOVA with Dunnetts post-test. B)
Expression of ORP8 in murine atherosclerotic plaques correlated with
expression of CD68 (P,0.001). Significance was assessed by linear
regression.
doi:10.1371/journal.pone.0109024.g001
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differentiating into a range of subtypes which vary widely in
inflammatory potential and wound healing ability, the extreme
ends of the subtype distribution being the pro-inflammatory M1
and the anti-inflammatory M2 macrophages [18,19,20]. BMDMs
were cultured from bone marrow of male ORP8 KO mice and
stimulated with LPS, IL-4 or left unstimulated to generate M1, M2
or naı¨ve macrophages, respectively. At 24 hours after stimulation
RNA was isolated and expression of macrophage differentiation
markers was measured. As anticipated, stimulation with LPS
induced the expression of the M1 markers IL-6 and TNFa, while
Figure 2. ORP8 KO BMDMs display reduced expression of macrophage differentiation factors and excrete less of pro-inflammatory
cytokines. Bone Marrow-Derived Macrophages (BMDM) were generated from bone marrow of ORP8 KO mice or WT controls and incubated with
LPS (100 ng/mL), IL-4 (20 ng/ml) or PBS. Expression of macrophage differentiation markers was measured by QPCR and calculated as relative to
housekeeping (HK) for the M1 markers IL-6 (A) and TNFa (B), the M2 markers FIZZ-1 (C), YM-1 (D), Arg1 (E), and ABCA1 (F) (N = 3). Significance was
determined by Student T-test, data are expressed as mean 6SEM. Statistical significant difference * P,0.05, ** P,0.01, *** P,0.001 as compared to
controls.
doi:10.1371/journal.pone.0109024.g002
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IL-4 stimulation led to augmented expression of the M2 markers
FIZZ-1, YM-1, and Arginase 1 (Arg1) (figure 2A–E). In LPS-
stimulated ORP8 KO BMDMs, a significant 2-fold decrease in
expression of the M1 marker IL-6 was found (P,0.01, figure 2A),
while no differences in expression of TNFa could be found
(figure 2B). Expression of the M2 marker FIZZ-1 was decreased 6-
fold in IL-4 stimulated ORP8 KO BMDMs (P,0.01, figure 2C).
There was also a trend towards a decrease in expression of YM-1
in ORP8 KO BMDMs in all treatment groups. However, this only
reached significance in the LPS-stimulated cells (P,0.05,
figure 2D), but expression of YM-1 under these conditions is
extremely low. No significant difference was found in the
expression of Arg1 (figure 2E). Expression of ABCA1 was
measured, as ORP8 has previously been shown to regulate
expression of ABCA1 [11]. There was a strong decrease in
expression of ABCA1 in naı¨ve macrophages and macrophages
stimulated with LPS and IL-4 (5-fold P,0.01, 3.4-fold P,0.001
and 2.9-fold P,0.01, respectively, figure 2F).
In addition to mRNA expression analysis, cytokine concentra-
tions in supernatant of LPS stimulated BMDMs were measured by
ELISA, showing decreased production of the pro-inflammatory
cytokines IL-6 (3.5-fold, P,0.01) and TNFa (4-fold, P,0.05) by
the ORP8 KO cells (figure 3A–B). Furthermore, the percentage of
unstimulated BMDMs expressing CD40 was decreased in the
ORP8 deficient group (0.6-fold, P,0.01), while there was also a
small, but significant decrease (0.9-fold, P,0.05) in the amount of
CD80 expressing ORP8 KO BMDMs after stimulation with LPS,
compared to WT BMDMs (figure 3C–D).
Increased Cholesterol and Triglycerides in the VLDL
fraction of blood from ORP8 KO BM recipient mice
To study the effect of macrophage ORP8 deletion on
atherosclerosis, bone marrow from ORP8 KO mice and WT
mice was transplanted into recipient LDLr KO animals. The
recipients were then fed a chow diet for 8 weeks and consecutively
WTD for a maximum of 9 weeks. No difference in body weight
was observed between the groups throughout the experiment. At
the end of both periods of dietary feeding blood was taken for lipid
analysis (table 1). Although there was a small increase in free
cholesterol in ORP8 KO BM recipients on chow diet at 18 weeks
after transplantation, no difference between the groups was found
after 6 and 9 weeks of WTD feeding. However, at 9 weeks of
WTD feeding a 1.4-fold increase in plasma triglycerides was found
in the ORP8 KO BM recipient mice (P,0.05, table 1). Serum
from animals after 9 weeks of WTD feeding was fractionated by
FPLC and analyzed for cholesterol and triglyceride content.
VLDL cholesterol was increased 1.2-fold in the ORP8 KO BM
recipients (P,0.05, figure 4A). While there was also a 1.2-fold
increase in total cholesterol, this failed to reach statistical
significance. Additionally, a 1.6-fold increase in VLDL triglycer-
ides was found (P,0.05, figure 4B). Following the observation that
IL-6 and TNFa secretion were decreased in ORP8 KO BMDMs,
IL6 and TNFa were measured in blood samples of the BM
recipients. However, the concentration of these cytokines was
below the threshold of detection (data not shown).
Figure 3. ORP8 KO BMDMs have reduced excretion of pro-inflammatory cytokines and reduced expression of co-stimulatory
factors. Bone Marrow-Derived Macrophages (BMDMs) were generated from bone marrow of ORP8 KO mice or WT controls and stimulated with LPS
(100 ng/mL). A) A decrease in secretion of IL-6 by LPS stimulated ORP8 KO BMDMs was measured using ELISA. (** P,0.01, N = 4) B) Similarly, TNFa
secretion was also decreased in LPS-stimulated ORP8 KO BMDMs. (* P,0.05, N = 4). Expression of co-stimulatory factors CD40 and CD80 on BMDMs
from ORP8 BM and WT BM was measured using FACS C) The percentage of unstimulated BMDMs expressing CD40 was decreased in the ORP8 KO
group. (** P,0.01, N= 5) D) After stimulation with LPS, the percentage of BMDMs expressing CD80 was decreased in the ORP8 KO group (* P,0.05,
N = 5). Significance of ELISA results was determined by Student T-test. Significance of FACS results was assessed by two-way ANOVA with Bonferroni
post-tests. Data are expressed as mean 6 SEM.
doi:10.1371/journal.pone.0109024.g003
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No change in circulating leukocytes, but increased
amounts of foam cells in the peritoneal cavity
After 9 weeks of WTD feeding, blood samples and peritoneal
lavage from LDLr KO mice transplanted with ORP8 KO BM or
WT BM were analyzed for leukocyte content. The number of
circulating leukocytes was not changed between the WT BM
recipients and the ORP8 KO BM recipients (figure 5A).
Furthermore, there was no detectable difference in leukocyte
composition, as the proportion of lymphocytes, monocytes and
neutrophils in blood were all unchanged (figure 5B–D).
Similarly, no difference in the total amount of leukocytes and
the proportion of lymphocytes and neutrophils was found in the
peritoneal cavity (figure 6A–C). However, there was a significant
35% increase in the proportion of peritoneal monocytes, but not
macrophages (P,0.05, figure 6D).
Decreased foam cell formation in the presence of
reduced ABCA1 expression in peritoneal cells of ORP8 KO
BM recipients, but unaffected macrophage cholesterol
efflux
Interestingly, although no difference in the amount of peritoneal
macrophages was found, the amount of foam cells in the
peritoneal cavity was strongly decreased (2.5-fold P,0.05,
figure 7A). Additionally, in line with the reduced expression of
ABCA1 in ORP8 KO BMDMs (figure 2F), ABCA1 expression in
ex-vivo peritoneal leukocytes from ORP8 KO BM recipients was
reduced 8-fold (P,0.01, figure 7B). However, no difference in
cholesterol efflux from 3H-cholesterol labeled BMDMs to ApoA1
or to HDL was observed (figure 7C), indicating that the level of
ABCA1 expression remained sufficiently high to maintain proper
macrophage cholesterol efflux.
Reduced atherosclerotic plaque size after 9 weeks
Western-type diet challenge, together with increased
macrophage area in plaques of ORP8 KO BM recipients
Despite the observed increased VLDL cholesterol and triglyc-
erides in the blood of the ORP8 KO BM recipients, Oil Red-O
staining of atherosclerotic plaques revealed a 20% reduction in
plaque size after 9 weeks of WTD feeding (P,0.05, figure 8A, F).
No significant difference in plaque size was found after 6 weeks of
WTD feeding, indicating that macrophage ORP8 deficiency did
not significantly affect development of early atherosclerotic
plaques of less than 200.000 mm2. Further morphological analysis
by MOMA-2 staining of atherosclerotic plaques after 9 weeks of
WTD challenge revealed that a 20% larger fraction of the plaques
in the ORP8 KO BM recipients was made up of macrophages
(P,0.05, figure 8B, F). Sections were stained with a Masson’s
Figure 4. Increased VLDL cholesterol and triglycerides in LDLr
KO mice receiving ORP8 KO bone marrow. Blood was isolated
from LDLr KO mice after transplantation with ORP8 KO bone marrow
(BM) or Wild Type (WT) BM. Lipoproteins were fractioned by size using
FPLC and cholesterol and triglyceride contents were measured in each
fraction. A) 17 weeks after transplantation and after 9 weeks of WTD
feeding ORP8 KO BM recipients exhibit increased VLDL cholesterol (*
P,0.05) B) Similarly, an increase in triglycerides in the VLDL fraction in
blood of ORP8 KO BM recipients on WTD was found (* P,0.05).
Significance was determined by Student t-test. N = 7, data are expressed
as mean 6SEM.
doi:10.1371/journal.pone.0109024.g004
Table 1. After 6 and 9 weeks of WTD feeding no difference in blood cholesterol levels was found between LDLr KO mice receiving
ORP8 KO BM or WT BM.
0 weeks 6 weeks 9 weeks
WT BM ORP8 KO BM WT BM ORP8 KO BM WT BM ORP8 KO BM
Body Weight (gr) 25.7 (60.4) 26.8 (61.0) 29.3 (61.3) 27.2 (60.7) 27.1 (60.9) 27.2 (60.6)
Triglycerides (mg/ml) - - - - 1263 (695) 1794 (6166)*
Free Cholesterol (mg/ml) 678 (620) 745 (619) 3966 (6259) 4151 (6203) 3665 (6194) 3749 (6229)
Esterified Cholesterol (mg/ml) 4467 (6175) 4468 (6138) 9336 (61003) 11577 (61552) 12901 (6759) 14185 (61129)
Total Cholesterol (mg/ml) 5148 (6189) 5213 (6139) 13302 (61273) 15727 (61723) 16566 (6939) 17934 (61351)
Body weight was measured during the chow feeding and the WTD feeding period, but no difference between the groups was found. At the end of the 9 weeks WTD
feeding period ORP8 KO BM recipients had increased blood triglycerides (TG) (N = 15, *P,0.05). Furthermore, free cholesterol (FC), cholesteryl esters (CE) and total
cholesterol (TC) were measured in WT BM and ORP8 KO BM recipients on chow diet and after 6 and 9 weeks on WTD. A small increase in FC was observed in the ORP8
KO BM recipients on chow diet, but no differences could be found after WTD feeding (N = 11, * P,0.05, significance was assessed by Student T-test with Welsh
correction if required). Results are expressed as mean 6 SEM.
doi:10.1371/journal.pone.0109024.t001
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Trichrome kit to visualize collagen deposition in the plaques.
However, no difference was found (figure 8C, F). Moreover,
TUNEL staining revealed no difference in the amount of
apoptotic cells in the plaque, indicating that deficiency of ORP8
in macrophages did not result in differences in cell death by
apoptosis. (figure 8D, F). In vitro studies using BMDMs indicated
decreased inflammatory potential of macrophages lacking ORP8,
as evidenced by a reduced secretion of cytokines IL-6 and TNFa
(figure 2G–H). Therefore also a CD3 staining was carried out to
quantify the T cells in the adventitia underlying the atherosclerotic
plaque, but no difference was found between the groups
(figure 8E, F).
Discussion
In the current study we showed that ORP8 expression is
increased during atherosclerotic lesion development, a process
which coincides with macrophage infiltration. This corresponds
with the finding that ORP8 is present in human atherosclerotic
plaques as opposed to healthy arteries, and is produced there by
macrophages [21]. To investigate the role of macrophage ORP8
in atherosclerotic lesion development we transplanted ORP8
knockout (KO) bone marrow into atherosclerosis susceptible LDLr
KO mice. Deletion of ORP8 in bone marrow-derived cells
resulted in increased levels of VLDL cholesterol and triglycerides
in the blood, but also a decrease in atherosclerotic plaque size.
ORP8 KO animals on a C57Bl/6 background exhibit increased
levels of HDL cholesterol in the blood, and increased ApoAI
production by hepatocytes [13]. Upon transplantation of ORP8
KO bone marrow into LDLr KO mice, we did not find any
differences in HDL cholesterol in the blood of the BM recipients.
This is not surprising, as the contribution of macrophages to HDL
formation is minor [22]. It is thus likely that the HDL phenotype
observed previously in the total body ORP8 KO animals is
primarily hepatocyte driven. In contrast, we did observe a marked
increase in VLDL cholesterol and triglycerides in ORP8 KO BM
recipient mice on WTD. Interestingly, also in total body ORP8
KO mice a strong tendency towards an increase in blood
triglycerides was observed, which in the female mice could be
ascribed to an increase in the VLDL fraction [13]. This change
was attributed to reduced lipoprotein lipase activity and possible
changes in SREBP signaling [13,23]. Hence, it is tempting to
speculate that the increase in VLDL triglycerides in the total body
ORP8 KO mice is the consequence of alterations induced by
deletion on ORP8 in bone marrow cells. Indeed, ORP8 mRNA
expression in liver samples of ORP8 KO BM recipients was
decreased. No differences in liver CD68 mRNA or Kupffer cell
numbers were observed, suggesting that ORP8 deletion likely
resulted in altered macrophage function but not viability (figure
S1). Whether the increased VLDL cholesterol and triglycerides in
our model, as opposed to the increase in HDL cholesterol
described previously is a consequence of the more pro-atherogenic
phenotype of the LDLr KO recipient mice requires further study.
VLDL cholesterol is a strong inducer of atherosclerosis
development, which makes the decrease in plaque development
after 9 weeks of WTD feeding in our model a striking finding [24].
Figure 5. No effect on blood leukocyte counts in LDLr KO mice receiving ORP8 KO bone marrow. At 17 weeks after transplantation and
after 9 weeks of WTD feeding, blood was isolated from bone marrow recipient animals. Blood leukocytes were counted using a hematology analyzer,
and different subpopulations were quantified as percentage of total leukocytes. A) No difference between the ORP8 KO BM recipients and the
wildtype (WT) BM recipients in the amount of circulating leukocytes. B–D) Similarly, there was no difference in the percentage of lymphocytes,
neutrophils and monocytes of total leukocytes. N = 15, results are expressed as mean 6SEM and significance was assessed by Student T-test.
doi:10.1371/journal.pone.0109024.g005
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In line with the decreased atherosclerosis, we also found reduced
foam cell formation in the peritoneal cavity of ORP8 KO BM
recipients. Macrophage foam cell formation is determined by a
disruption of the balance of cholesterol synthesis, cholesterol influx
and cholesterol efflux. Considering the observed increased levels of
VLDL cholesterol, it is unlikely that the decreased foam cell
formation is due to decreased influx. Moreover, the reduced foam
cell formation could not be explained by enhanced cholesterol
efflux as ex vivo cholesterol efflux experiments failed to show
significant differences. Notably ABCA1 mRNA expression was
reduced both ex vivo in peritoneal macrophages and in vitro in
bone marrow-derived macrophages.
Previous publications have reported an increase in ABCA1
expression when expression of ORP8 was ablated, both in THP-1
cells and in female mouse liver samples [11,13]. In THP-1 cells,
the increase in ABCA1 expression after siRNA mediated silencing
Figure 6. Increase in peritoneal monocytes in LDLr KO mice receiving ORP8 KO BM, but decrease in peritoneal foam cells. Peritoneal
leukocytes were isolated from ORP8 KO BM recipients and wild type BM recipients and counted using a hematology analyzer at 17 weeks after BMT
and 9 weeks WTD feeding. A) No difference between treatment groups was found in the total number of peritoneal leukocytes. B) The amount of
peritoneal lymphocytes did not differ between the groups. C) Similarly, there was no difference between the groups in the amount of neutrophils in
the peritoneum. D) However, there was an increase in the percentage of peritoneal monocytes out of total leukocytes in the ORP8 KO BM recipients,
but no difference in macrophage content (* P,0.05). N = 15, significance was assessed by Student T-test. Results are expressed as mean 6SEM.
doi:10.1371/journal.pone.0109024.g006
Figure 7. Reduced peritoneal foam cell formation and lower expression of ABCA1 in ORP8 KO macrophages, but no change in
cellular cholesterol efflux. Expression of ABCA1 was measured by QPCR in Peritoneal Leukocytes isolated from LDLr KO mice at 17 weeks after
transplantation with WT BM or ORP8 KO BM and 9 weeks WTD feeding. A) The ORP8 KO transplanted group displays a reduced amount of foam cells
when expressed as a percentage of total peritoneal leukocytes. B) In line, expression of ABCA1 in peritoneal leukocytes of ORP8 KO BM recipients is
reduced. (** P,0.01, N= 4) C) However, no change in cholesterol efflux of BMDMs to ApoA1 or HDL was found (N=5). Results are expressed as mean
6 SEM after subtraction of baseline efflux to BSA. Significance was determined by Student t-test.
doi:10.1371/journal.pone.0109024.g007
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of ORP8 was accompanied with increased cholesterol efflux to
apoA-I [11]. In livers of female ORP8 KO mice expression of
ABCA1 was also strongly increased, but this did not translate into
a difference in protein expression. In contrast, in male ORP8 KO
mice hepatic expression of ABCA1 showed a trend towards a
decrease in expression on both RNA and on protein levels. In line,
in our study the bone marrow donors were male and we observed
a decrease in ABCA1 expression both in peritoneal leukocytes and
in BMDMs. Lentiviral silencing of ORP8 in RAW 264.7 cells
results in a modest increase in SREBP1 and SREBP2 expression,
and ORP8 silencing in HuH7 cells leads to increased expression of
SREBP target genes, including HMG-CoA reductase and LDLr
Figure 8. Decreased plaque size in ORP8 KO BM recipients and increased plaque macrophage content after 9 weeks WTD feeding.
A) Plaque size was quantified in Oil Red O stained sections. After 9 weeks of WTD feeding following BMT, a decrease in plaque size could be
measured. No difference was observed after 6 weeks of dietary challenge. (N = 13 * P,0.05, data was analyzed by two-way ANOVA with Bonferroni
post-tests) B) Plaque macrophages were visualized using MoMa2 staining and quantified as a percentage of total plaque area. After 9 weeks of WTD
feeding, an increase in the MoMa2 positive fraction was detected in the ORP8 KO BM recipients. (N = 13 * P,0.05, data was analyzed by two-way
ANOVA with Bonferroni post-tests) C) Collagen was visualized by staining plaques from ORP8 BM and WT BM recipients with a Masson’s Trichrome
(MTC) kit, but no difference was found between the groups (N= 15, significance was assessed by Student T test). D) Apoptotic cells in atherosclerotic
plaques of ORP8 KO BM recipients and WT BM controls were visualized by TUNEL staining. No difference in the amount of apoptotic cells was
detected between treatment groups (N= 8, significance was assessed by Student T test). E) Aortic root sections from ORP8 KO BM recipients and WT
BM controls were stained for CD3 to detect T cells. No difference between the groups was detected (N= 8, significance was assessed by Student T
test). F) Representative images of Oil-Red O (ORO), MoMa2, TUNEL, CD3 and MTC stainings performed on atherosclerotic plaques of mice receiving
ORP8 KO BM or WT BM. Images of ORO, Moma2 and MTC stainings, original magnification 56. Images of TUNEL and CD3 stainings, original
magnification 206.
doi:10.1371/journal.pone.0109024.g008
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[23,25]. ORP8 likely affects ABCA1 expression by interfering with
LXR signaling and SREBP activity [21,23,24]. The reduction in
ABCA1 expression did not translate into differences in macro-
phage cholesterol efflux. ABCA1 mRNA expression is not always
an accurate reflection for ABCA1 protein abundance, and
previous studies on ORP8 KO liver have demonstrated changes
in ABCA1 mRNA expression without corresponding changes in
protein levels [13,21]. Alternatively, the level of ABCA1 expres-
sion was still sufficient for maintaining a proper cholesterol efflux
capacity under the studied conditions. In the current study the
reduction in ABCA1 expression could also simply be a result of the
observed reduction in lipid loading in the peritoneal cells. Previous
studies in male ORP8 KO mice showed decreased expression of
HMG-CoA reductase [13]. The down-regulation of HMG-CoA
reductase, which is the rate limiting enzyme for cholesterol
production, could result in reduced cholesterol loading. This might
explain that ORP8 deletion resulted in reduced in vivo
macrophage foam cell formation. Importantly, the reduced foam
cell formation upon deletion of ORP8 in bone marrow-derived
cells could have contributed to the observed reduction in lesion
development. This however does not explain why macrophage
ORP8 deletion primarily affects the progression of early athero-
sclerotic lesions, rich in macrophage foam cells, to more advance
atherosclerotic lesions. In vitro studies using bone marrow-derived
macrophages also point towards a role for ORP8 in regulation of
macrophage differentiation toward different subtypes.
A study by Beaslas et al. has demonstrated that silencing of
ORP8 expression in the murine RAW 264.7 macrophage cell line
results in down regulation of gene pathways associated with
lysosomal function, growth-factor activity and immunity Major
Histocompatibility Complex type I (MCH-I) function and
increased macrophage migration [25]. This could result in a
reduced capacity to present antigens to immune cells such as T-
cells [26]. In line, the observed decrease in CD40 and CD80
expression in ORP8 KO BMDMs indicates a reduced co-
stimulatory potential and a decreased capacity to activate T-cells
[26]. In the current study we also demonstrated a decrease in
mRNA expression of IL-6 and excretion of TNFa and IL-6 by
LPS-stimulated M1 BMDMs lacking ORP8. Furthermore, mRNA
expression of the M2 markers YM-1 and FIZZ-1 was decreased.
Upon deletion of ORP8, macrophages thus show a reduced
polarization towards both M1 and M2 subtypes [27]. The effects
of ORP8 deficiency on macrophage inflammatory signaling could
provide a mechanistic explanation for the increase in VLDL levels
in mice lacking macrophage ORP8. However, decreased excretion
of TNFa and IL-6 would lead to decreased synthesis of cholesterol,
triglycerides and VLDL particles [28]. Therefore it is unlikely that
the observed increase in VLDL levels in ORP8 KO BM recipients
can be attributed to a decrease in production of pro-inflammatory
cytokines by Kupffer cells lacking ORP8.
Importantly, macrophage differentiation plays a crucial role in
the advanced stages of atherosclerotic plaque development.
‘‘Wound healing’’ M2 macrophages promote plaque stability,
whereas ‘‘classically activated’’ M1 macrophages contribute to the
thinning of the fibrous cap [29]. Both types of macrophages can be
found in advanced plaques, creating a complex dynamic
equilibrium that determines the structure of the plaque and its
likelihood to rupture [18,29,30,31]. In human plaques, expression
of ORP8 is localized in the shoulder region [11]. Research on
human carotid artery sections has shown that macrophages in the
shoulder region of the plaque strongly exhibit markers of M1
macrophages such as iNOS and HLA [29]. Moreover, an increase
in TNFa and IL-6 mRNA is observed in ruptured plaque
segments [29]. By producing pro-inflammatory factors such as
TNFa and IL-6, M1 macrophages are able to drive the
inflammatory reaction and thereby enhance the development of
atherosclerosis [32,33,34,35]. The observed decrease in the
production of TNFa and IL-6 and reduced expression of co-
stimulatory molecules by macrophages lacking ORP8 is thus
expected to lead to reduced inflammatory activity in the plaque.
In summary, ORP8 KO macrophages have a decreased ability
to drive atherosclerosis due to lowered production of pro-
inflammatory cytokines and a reduced formation of foam cells.
In concert, these two effects may result in a reduced size of
atherosclerotic plaques in ORP8 KO BM recipients after 9 weeks
of WTD feeding, despite the observed increase in VLDL
cholesterol and triglycerides.
Supporting Information
Figure S1 Transplantation of LDLr KO mice with ORP8
KO bone marrow (BM) results in decreased expression
of ORP8 in the liver, but no changes in Kupffer cell
content. Livers were isolated at 17 weeks after transplantation
and after 9 weeks of WTD feeding. A) A reduction in RNA
expression of ORP8 as a fraction of housekeeping (HK) in liver
lysates was measured by QPCR (* P,0.05). B) No difference in
expression of the macrophage marker CD68 could be detected
using QPCR. C) Liver sections were stained for F4/80 and F4/80
positive cells were quantified as percentage of total cells counted.
No difference in liver F4/80 positive cells could be found. D)
Representative images of F4/80 stained liver sections. Original
magnification 406. Significance was determined by Student T-
test.
(TIF)
Author Contributions
Conceived and designed the experiments: EvK OB TJCvB VMO MvE.
Performed the experiments: EvK OB RBH BL. Analyzed the data: EvK
OB RBH. Contributed reagents/materials/analysis tools: EvK VMO
MvE. Wrote the paper: EvK TJCvB VMO MvE.
References
1. Olkkonen VM, Johansson M, Suchanek M, Yan D, Hynynen R, et al. (2006)
The OSBP-related proteins (ORPs): global sterol sensors for co-ordination of
cellular lipid metabolism, membrane trafficking and signalling processes?
Biochemical Society transactions 34: 389–391.
2. Shibata N, Glass CK (2010) Macrophages, oxysterols and atherosclerosis.
Circulation journal: official journal of the Japanese Circulation Society 74:
2045–2051.
3. Im SS, Osborne TF (2011) Liver6receptors in atherosclerosis and inflammation.
Circulation research 108: 996–1001.
4. Lemaire-Ewing S, Prunet C, Montange T, Vejux A, Berthier A, et al. (2005)
Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics
of different oxysterols. Cell biology and toxicology 21: 97–114.
5. Vihervaara T, Uronen RL, Wohlfahrt G, Bjorkhem I, Ikonen E, et al. (2011)
Sterol binding by OSBP-related protein 1L regulates late endosome motility and
function. Cellular and molecular life sciences: CMLS 68: 537–551.
6. Yan D, Jauhiainen M, Hildebrand RB, Willems van Dijk K, Van Berkel TJ,
et al. (2007) Expression of human OSBP-related protein 1L in macrophages
enhances atherosclerotic lesion development in LDL receptor-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 27: 1618–1624.
7. Lehto M, Mayranpaa MI, Pellinen T, Ihalmo P, Lehtonen S, et al. (2008) The
R-Ras interaction partner ORP3 regulates cell adhesion. Journal of cell science
121: 695–705.
8. Du X, Kumar J, Ferguson C, Schulz TA, Ong YS, et al. (2011) A role for
oxysterol-binding protein-related protein 5 in endosomal cholesterol trafficking.
The Journal of cell biology 192: 121–135.
ORP8 KO BMT Results in Reduced Atherosclerosis
PLOS ONE | www.plosone.org 10 October 2014 | Volume 9 | Issue 10 | e109024
9. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al.
(2010) Biological, clinical and population relevance of 95 loci for blood lipids.
Nature 466: 707–713.
10. Ma L, Yang J, Runesha HB, Tanaka T, Ferrucci L, et al. (2010) Genome-wide
association analysis of total cholesterol and high-density lipoprotein cholesterol
levels using the Framingham heart study data. BMC medical genetics 11: 55.
11. Yan D, Mayranpaa MI, Wong J, Perttila J, Lehto M, et al. (2008) OSBP-related
protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from
macrophages. The Journal of biological chemistry 283: 332–340.
12. Tall AR (2003) Role of ABCA1 in cellular cholesterol efflux and reverse
cholesterol transport. Arteriosclerosis, thrombosis, and vascular biology 23: 710–
711.
13. Beaslas O, Metso J, Nissila E, Laurila PP, Kaiharju E, et al. (2013) Osbpl8
deficiency in mouse causes an elevation of high-density lipoproteins and gender-
specific alterations of lipid metabolism. PloS one 8: e58856.
14. von der Thusen JH, van Berkel TJ, Biessen EA (2001) Induction of rapid
atherogenesis by perivascular carotid collar placement in apolipoprotein E-
deficient and low-density lipoprotein receptor-deficient mice. Circulation 103:
1164–1170.
15. Van Eck M, Bos IS, Hildebrand RB, Van Rij BT, Van Berkel TJ (2004) Dual
role for scavenger receptor class B, type I on bone marrow-derived cells in
atherosclerotic lesion development. The American journal of pathology 165:
785–794.
16. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid
guanidinium thiocyanate-phenol-chloroform extraction. Analytical biochemistry
162: 156–159.
17. Redgrave TG, Roberts DC, West CE (1975) Separation of plasma lipoproteins
by density-gradient ultracentrifugation. Analytical biochemistry 65: 42–49.
18. Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, et al. (2011) HDL
promotes rapid atherosclerosis regression in mice and alters inflammatory
properties of plaque monocyte-derived cells. Proceedings of the National
Academy of Sciences of the United States of America 108: 7166–7171.
19. Patel PJ, Khera AV, Wilensky RL, Rader DJ (2013) Anti-oxidative and
cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic
cardiomyopathy. European journal of heart failure.
20. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM (1998) Oxidized LDL
regulates macrophage gene expression through ligand activation of PPAR-
gamma. Cell 93: 229–240.
21. Wellington CL, Walker EK, Suarez A, Kwok A, Bissada N, et al. (2002) ABCA1
mRNA and protein distribution patterns predict multiple different roles and
levels of regulation. Laboratory investigation; a journal of technical methods
and pathology 82: 273–283.
22. Haghpassand M, Bourassa PA, Francone OL, Aiello RJ (2001) Monocyte/
macrophage expression of ABCA1 has minimal contribution to plasma HDL
levels. The Journal of clinical investigation 108: 1315–1320.
23. Zhou T, Li S, Zhong W, Vihervaara T, Beaslas O, et al. (2011) OSBP-related
protein 8 (ORP8) regulates plasma and liver tissue lipid levels and interacts with
the nucleoporin Nup62. PloS one 6: e21078.
24. Mahley RW, Innerarity TL, Rall SC, Jr., Weisgraber KH (1985) Lipoproteins of
special significance in atherosclerosis. Insights provided by studies of type III
hyperlipoproteinemia. Annals of the New York Academy of Sciences 454: 209–
221.
25. Beaslas O, Vihervaara T, Li J, Laurila PP, Yan D, et al. (2012) Silencing of
OSBP-related protein 8 (ORP8) modifies the macrophage transcriptome,
nucleoporin p62 distribution, and migration capacity. Experimental cell research
318: 1933–1945.
26. Dion S, Germon S, Guiton R, Ducournau C, Dimier-Poisson I (2011)
Functional activation of T cells by dendritic cells and macrophages exposed to
the intracellular parasite Neospora caninum. International journal for
parasitology 41: 685–695.
27. Nair MG, Cochrane DW, Allen JE (2003) Macrophages in chronic type 2
inflammation have a novel phenotype characterized by the abundant expression
of Ym1 and Fizz1 that can be partly replicated in vitro. Immunology letters 85:
173–180.
28. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, et al. (2004)
Effects of infection and inflammation on lipid and lipoprotein metabolism:
mechanisms and consequences to the host. Journal of lipid research 45: 1169–
1196.
29. Stoger JL, Gijbels MJ, van der Velden S, Manca M, van der Loos CM, et al.
(2012) Distribution of macrophage polarization markers in human atheroscle-
rosis. Atherosclerosis 225: 461–468.
30. Cho KY, Miyoshi H, Kuroda S, Yasuda H, Kamiyama K, et al. (2013) The
phenotype of infiltrating macrophages influences arteriosclerotic plaque
vulnerability in the carotid artery. Journal of stroke and cerebrovascular
diseases: the official journal of National Stroke Association 22: 910–918.
31. Oh J, Riek AE, Weng S, Petty M, Kim D, et al. (2012) Endoplasmic reticulum
stress controls M2 macrophage differentiation and foam cell formation. The
Journal of biological chemistry 287: 11629–11641.
32. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The
chemokine system in diverse forms of macrophage activation and polarization.
Trends in immunology 25: 677–686.
33. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, et al. (2000) Elevation of
tumor necrosis factor-alpha and increased risk of recurrent coronary events after
myocardial infarction. Circulation 101: 2149–2153.
34. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration
of interleukin-6 and the risk of future myocardial infarction among apparently
healthy men. Circulation 101: 1767–1772.
35. Naugler WE, Karin M (2008) The wolf in sheep’s clothing: the role of
interleukin-6 in immunity, inflammation and cancer. Trends in molecular
medicine 14: 109–119.
ORP8 KO BMT Results in Reduced Atherosclerosis
PLOS ONE | www.plosone.org 11 October 2014 | Volume 9 | Issue 10 | e109024
